Future studies are required to further characterize the relationship between hepcidin, erythropoiesis and anemia, and to directly assess the effect of iron supplementation in SCD on hepcidin levels and iron absorption with a view to establish its role in the management of SCD and possible iron deficiency. The gene discussed is HAMP; the disease is nutritional disorder.